INTERSECT ENT INC (XENT) Forecast, Price Target & Analyst Ratings
NASDAQ:XENT • US46071F1030
28.24
0 (0%)
At close: May 12, 2022
28.24
0 (0%)
After Hours: 5/12/2022, 8:00:03 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INTERSECT ENT INC (XENT).
Forecast Snapshot
Consensus Price Target
$28.82
+ 2.04% Upside
Next Earnings Forecast
Release DateAug 4, 2022
PeriodQ2 / 2022
EPS Estimate-$0.33
Revenue Estimate32.538M
ChartMill Buy Consensus
45.71%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$28.82
Upside
+ 2.04%
From current price of $28.24 to mean target of $28.82, Based on 7 analyst forecasts
Low
$28.53
Median
$28.82
High
$29.66
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for XENT. The average price target is 28.82 null. This implies a price increase of 2.04% is expected in the next year compared to the current price of 28.24.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
XENT was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about XENT.
In the previous month the buy percentage consensus was at a similar level.
XENT was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-08-12 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2021-08-10 | BTIG | Downgrade | Buy -> Neutral |
| 2021-08-09 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-08-09 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2021-06-24 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-05-11 | SVB Leerink | Maintains | Market Perform |
| 2021-03-10 | SVB Leerink | Maintains | Market Perform |
Next Earnings Forecast Details
Next Earnings Details
Release DateAug 4, 2022
PeriodQ2 / 2022
EPS Estimate-$0.33
Revenue Estimate32.538M
Revenue Q2Q18.97%
EPS Q2Q33.39%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
XENT is expected to report earnings on 8/4/2022. The consensus EPS estimate for the next earnings is -0.33 null and the consensus revenue estimate is 32.54M null.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 109.1M 0.55% | 80.6M -26.12% | 106.75M 32.44% | 137.817M 29.10% | 172.486M 25.16% | 202.431M 17.36% | 242.327M 19.71% | |
| EBITDA YoY % growth | -41.5M -79.50% | -62.63M -50.92% | -67.87M -8.37% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -45.4M -81.60% | -67.7M -49.12% | -72.68M -7.36% | N/A | N/A | N/A | N/A | |
| Operating Margin | -41.61% | -84.00% | -68.08% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -1.37 -80.26% | -2.16 -57.66% | N/A 16.79% | -1.13 37.00% | -1.10 2.52% | -1.30 -17.41% | -1.55 -19.76% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.33 33.39% | -0.30 38.38% | -0.18 44.62% |
| Revenue Q2Q % growth | 32.538M 18.97% | 36.164M 48.21% | 42.748M 39.38% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.55%
EPS Next 5 Year
3.25%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
18.84%
Revenue Next 5 Year
19.06%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
INTERSECT ENT INC / XENT Forecast FAQ
What do analysts expect the price target to be for INTERSECT ENT INC (XENT)?
7 analysts have analysed XENT and the average price target is 28.82 null. This implies a price increase of 2.04% is expected in the next year compared to the current price of 28.24.
What is the next earnings date for XENT stock?
INTERSECT ENT INC (XENT) will report earnings on 2022-08-04.
What are the consensus estimates for INTERSECT ENT INC (XENT) next earnings?
The consensus EPS estimate for the next earnings of INTERSECT ENT INC (XENT) is -0.33 null and the consensus revenue estimate is 32.54M null.
What is the consensus rating for INTERSECT ENT INC (XENT) stock?
The consensus rating for INTERSECT ENT INC (XENT) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.